Anti-CLPTM1 like antibodies are used for the immunodetection of the protein encoded by the CLPTM1L gene. In humans, the canonical protein has a reported length of 538 amino acid residues and a mass of 62.2 kDa. Its subcellular localization is in the ER. Alternative splicing is reported to yield 2 different isoforms for this protein. It is ubiquitously expressed across many tissue types. A member of the CLPTM1 protein family, it is a reported scramblase that mediates the translocation of glucosaminylphosphatidylinositol (alpha-D-GlcN-(1-6)-(1,2-diacyl-sn-glycero-3-phospho)-1D-myo-inositol, GlcN-PI) across the endoplasmic reticulum (ER) membrane, from the cytosolic leaflet to the luminal leaflet of the ER membrane, where it participates in the biosynthesis of glycosylphosphatidylinositol (GPI). Other names for this target antigen include CLPTM1-like protein, cisplatin resistance related protein CRR9p, cisplatin resistance-related protein 9, cleft lip and palate transmembrane protein 1-like protein, and lipid scramblase CLPTM1L. A number of CLPTM1 like antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA, Immunocytochemistry, Immunofluorescence, and Immunohistochemistry are also common applications.